Mark A. Fisher, PhD

Professor (Clinical), University of Utah School of Medicine

Specialties

• Microbial pathogenesis
• Transmission of vector borne pathogens

Education

• Master Degree—Microbiology, Idaho State University
• Doctorate Degree—Microbiology and Molecular Genetics, Emory University
• Fellowship—Medical Microbiology, University of Utah School of Medicine

Certification/Affiliations

• American Board of Medical Microbiology

Research Interests

• Microbial pathogenesis
• Transmission of vector borne pathogens

Awards

• Young Investigator Award, 2012 Mass Spectrometry-Applications for the Clinical Laboratory (MSACL), 2012
• NIH-Rocky Mountain Regional Center of Excellence in Biodefense (RMRCE) Career Development Award, 2006–09
• NIH Summer Post-Doctoral Research and Training Award, 2002–06

Recent Publications

• Forde BM, Roberts LW, Phan MD, et al. Population dynamics of an E. coli ST131 lineage during recurrent urinary tract infection. Nat Commun. 2019;10(1):3643.
• Lacy MD, Fisher MA. Sepsis, helicoid bacteremia, and pneumatosis intestinalis. Infect Dis Clin Pract. 2019;27(5):292-294.
• Langelier C, Graves M, Kalantar K,  et al. Microbiome and antimicrobial resistance gene dynamics in international travelers. Emerg Infect Dis. 2019;25(7):1380-1383.
• Tanner WD, VanDerslice JA, Goel RK, et al. Multi-state study of Enterobacteriaceae harboring extended-spectrum beta-lactamase and carbapenemase genes in U.S. drinking water. Sci Rep. 2019;9(1):3938.
• Shakir SM, Powers-Fletcher MV, Slechta ES, et al. Helicobacter canis bacteraemia and cellulitis in a patient with end-stage renal disease. JMM Case Rep. 2017;4(11):e005126.
• Prasidthrathsint K, Fisher MA. Antimicrobial susceptibility patterns among a large, nationwide cohort of abiotrophia and granulicatella clinical isolates. J Clin Microbiol. 2017;55(4):1025-1031.